JP7318818B2 - 慢性腎臓病のネコの治療方法 - Google Patents

慢性腎臓病のネコの治療方法 Download PDF

Info

Publication number
JP7318818B2
JP7318818B2 JP2022542656A JP2022542656A JP7318818B2 JP 7318818 B2 JP7318818 B2 JP 7318818B2 JP 2022542656 A JP2022542656 A JP 2022542656A JP 2022542656 A JP2022542656 A JP 2022542656A JP 7318818 B2 JP7318818 B2 JP 7318818B2
Authority
JP
Japan
Prior art keywords
kidney disease
chronic kidney
cats
stage
bps
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022542656A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022265031A5 (https=
JPWO2022265031A1 (https=
Inventor
巧 松浦
元 車谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Publication of JPWO2022265031A1 publication Critical patent/JPWO2022265031A1/ja
Publication of JPWO2022265031A5 publication Critical patent/JPWO2022265031A5/ja
Application granted granted Critical
Publication of JP7318818B2 publication Critical patent/JP7318818B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2022542656A 2021-06-16 2022-06-15 慢性腎臓病のネコの治療方法 Active JP7318818B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021100475 2021-06-16
JP2021100475 2021-06-16
PCT/JP2022/023876 WO2022265031A1 (ja) 2021-06-16 2022-06-15 慢性腎臓病のネコの治療方法

Publications (3)

Publication Number Publication Date
JPWO2022265031A1 JPWO2022265031A1 (https=) 2022-12-22
JPWO2022265031A5 JPWO2022265031A5 (https=) 2023-05-30
JP7318818B2 true JP7318818B2 (ja) 2023-08-01

Family

ID=84527566

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022542656A Active JP7318818B2 (ja) 2021-06-16 2022-06-15 慢性腎臓病のネコの治療方法

Country Status (11)

Country Link
US (1) US12097177B2 (https=)
EP (1) EP4356908B1 (https=)
JP (1) JP7318818B2 (https=)
KR (1) KR20240021749A (https=)
CN (1) CN117396197A (https=)
AU (1) AU2022294552A1 (https=)
BR (1) BR112023023965A2 (https=)
CA (1) CA3217697A1 (https=)
ES (1) ES3054744T3 (https=)
MX (1) MX2023013545A (https=)
WO (1) WO2022265031A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025501556A (ja) * 2021-12-27 2025-01-22 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 慢性腎臓病を診断及び治療するための組成物及び方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016031949A1 (ja) 2014-08-28 2016-03-03 東レ株式会社 慢性腎不全の治療薬
WO2021132302A1 (ja) 2019-12-23 2021-07-01 東レ株式会社 透析移行又は腎死の抑制のための薬剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58124778A (ja) 1982-01-20 1983-07-25 Toray Ind Inc ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
JPH075582B2 (ja) 1986-01-24 1995-01-25 東レ株式会社 ２，５，６，７−テトラノル−４，８−インタ−ｍ−フエニレンＰＧＩ▲下２▼誘導体
JPH0662599B2 (ja) 1987-10-16 1994-08-17 東レ株式会社 ２，５，６，７―テトラノル―４，８―インタ―ｍ―フェニレンＰＧＩ２誘導体ならびにその製造法および用途
CA2012081C (en) 1989-03-14 2000-08-29 Shigeki Itou 2,5,6,7-tetranor-4,8-inter-m-phenylene pgi 2 derivatives
WO1998041210A1 (en) 1997-03-14 1998-09-24 Toray Industries, Inc. Sustained-release prostaglandin i derivative preparation
ES2272914T3 (es) 2003-05-20 2007-05-01 Ethypharm Composicion farmaceutica oral de liberacion sostenida.
CN101217960B (zh) 2005-07-08 2010-12-15 东丽株式会社 用于改善尿毒症的治疗药和处置方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016031949A1 (ja) 2014-08-28 2016-03-03 東レ株式会社 慢性腎不全の治療薬
WO2021132302A1 (ja) 2019-12-23 2021-07-01 東レ株式会社 透析移行又は腎死の抑制のための薬剤

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
IRIS Staging of CKD (modified 2019)，2019年，p.1-5
Journal of Veterinary Internal Medicine，2008年，Vol.22, Issue 5，p.1111-1117
Journal of Veterinary Internal Medicine，2018年，Vol.32, Issue 1，p.236-248

Also Published As

Publication number Publication date
MX2023013545A (es) 2023-11-29
EP4356908A4 (en) 2024-10-23
US12097177B2 (en) 2024-09-24
WO2022265031A1 (ja) 2022-12-22
EP4356908A1 (en) 2024-04-24
CA3217697A1 (en) 2022-12-22
AU2022294552A1 (en) 2023-11-02
CN117396197A (zh) 2024-01-12
JPWO2022265031A1 (https=) 2022-12-22
US20240207218A1 (en) 2024-06-27
BR112023023965A2 (pt) 2024-01-30
EP4356908C0 (en) 2025-10-22
ES3054744T3 (en) 2026-02-05
KR20240021749A (ko) 2024-02-19
EP4356908B1 (en) 2025-10-22
TW202317089A (zh) 2023-05-01

Similar Documents

Publication Publication Date Title
JP2016053057A (ja) 糖尿病の合併症のための療法
JP7402907B2 (ja) ネコの全身性疾患の予防又は治療用アンジオテンシンｉｉ受容体拮抗薬
JP7318818B2 (ja) 慢性腎臓病のネコの治療方法
RS67322B1 (sr) Dapagliflozin za upotrebu u postupcima lečenja hronične bolesti bubrega
TWI867128B (zh) 前列腺環素衍生物用於製造用以抑制轉入透析或腎死之藥劑之用途
JP5018478B2 (ja) 尿毒症改善のための治療剤および処置方法
EP4347022A1 (en) Pediatric formulations of ferric citrate
CN116887843A (zh) 用于降低接受维持性透析的患者中的草酸盐/酯水平的组合物和方法
Quintavalla et al. The effect of different opioids on acid-base balance and blood gas analysis in hospitalized dogs
RU2778313C2 (ru) Лекарственная композиция, включающая ингибитор sglt-2 и блокатор рецептора ангиотензина
CA3067918C (en) Angiotensin ii receptor antagonish for the prevention or treatment of hypertension in cats
US20230049917A1 (en) Pharmaceutical Composition of CASR Modulators and Methods and Uses Thereof
Parker et al. Nephrotoxins and drugs in renal insufficiency
CN121243400A (zh) 治疗高血清磷酸盐相关疾病的联合给药方法和药物组合物
EP2763662A1 (en) Pharmaceutical compositions of antihypertensives

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230308

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230308

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20230308

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230411

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230511

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230511

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230530

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230612

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230620

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230703

R151 Written notification of patent or utility model registration

Ref document number: 7318818

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151